TGF β RII Antibodies

Santa Cruz Biotechnology provides a broad selection of TGF β RII monoclonal antibodies for investigating transforming growth factor beta receptor type II. TGF β RII Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TGF β RII plays a crucial role in mediating the effects of TGF-β, a key regulator of cell growth, differentiation, and immune response. The receptor is essential for the proper functioning of various cellular processes, including tissue repair and fibrosis, making it a significant target in cancer research and therapeutic development. Understanding the signaling pathways involving TGF β RII can provide insights into disease mechanisms and potential treatment strategies. Researchers worldwide rely on TGF β RII monoclonal antibodies to advance their studies in cell signaling pathways. The specificity and reliability of TGF β RII monoclonal antibodies enable detailed examination of receptor expression and distribution patterns across different tissue types. Santa Cruz Biotechnology monoclonal antibodies for TGF β RII support breakthrough discoveries in cancer biology, immunology, and regenerative medicine research.